Hhlr Advisors LTD. Acquires 3,975 Shares of Danaher Co. (NYSE:DHR)

Hhlr Advisors LTD. boosted its stake in shares of Danaher Co. (NYSE:DHR) by 43.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,079 shares of the conglomerate’s stock after buying an additional 3,975 shares during the quarter. Danaher makes up approximately 0.1% of Hhlr Advisors LTD.’s portfolio, making the stock its 27th largest holding. Hhlr Advisors LTD.’s holdings in Danaher were worth $3,002,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in DHR. Heck Capital Advisors LLC purchased a new position in Danaher in the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher during the 4th quarter worth $31,000. Golden State Wealth Management LLC purchased a new stake in Danaher during the fourth quarter valued at about $31,000. Strategic Financial Concepts LLC purchased a new position in shares of Danaher in the fourth quarter worth about $31,000. Finally, Pineridge Advisors LLC lifted its stake in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

DHR has been the subject of a number of recent analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Raymond James restated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a research report on Friday, March 14th. The Goldman Sachs Group dropped their price target on Danaher from $260.00 to $240.00 and set a “neutral” rating for the company in a research report on Wednesday, April 23rd. Finally, Wells Fargo & Company dropped their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $264.40.

Danaher Stock Down 0.6 %

Shares of NYSE:DHR opened at $196.01 on Tuesday. The stock’s 50-day moving average is $200.69 and its 200 day moving average is $223.46. The company has a market cap of $140.28 billion, a PE ratio of 37.12, a P/E/G ratio of 2.66 and a beta of 0.86. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The firm had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. Sell-side analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 25th. Investors of record on Friday, March 28th were given a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is currently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.